Free Trial
NASDAQ:HCM

HUTCHMED (HCM) Stock Price, News & Analysis

HUTCHMED logo
$13.86 +0.63 (+4.76%)
Closing price 04:00 PM Eastern
Extended Trading
$13.86 +0.01 (+0.04%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HUTCHMED Stock (NASDAQ:HCM)

Key Stats

Today's Range
$13.51
$13.90
50-Day Range
$11.81
$16.06
52-Week Range
$11.51
$21.50
Volume
61,240 shs
Average Volume
100,445 shs
Market Capitalization
$2.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00
Consensus Rating
Hold

Company Overview

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

HUTCHMED Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

HCM MarketRank™: 

HUTCHMED scored higher than 40% of companies evaluated by MarketBeat, and ranked 715th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HUTCHMED has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HUTCHMED has only been the subject of 1 research reports in the past 90 days.

  • Read more about HUTCHMED's stock forecast and price target.
  • Earnings Growth

    Earnings for HUTCHMED are expected to grow by 812.50% in the coming year, from $0.16 to $1.46 per share.

  • Price to Book Value per Share Ratio

    HUTCHMED has a P/B Ratio of 3.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about HUTCHMED's valuation and earnings.
  • Percentage of Shares Shorted

    0.26% of the float of HUTCHMED has been sold short.
  • Short Interest Ratio / Days to Cover

    HUTCHMED has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in HUTCHMED has recently increased by 2.82%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    HUTCHMED does not currently pay a dividend.

  • Dividend Growth

    HUTCHMED does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.26% of the float of HUTCHMED has been sold short.
  • Short Interest Ratio / Days to Cover

    HUTCHMED has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in HUTCHMED has recently increased by 2.82%, indicating that investor sentiment is decreasing.
  • News Sentiment

    HUTCHMED has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for HUTCHMED this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, HUTCHMED insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.60% of the stock of HUTCHMED is held by insiders.

  • Percentage Held by Institutions

    Only 8.82% of the stock of HUTCHMED is held by institutions.

  • Read more about HUTCHMED's insider trading history.
Receive HCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HUTCHMED and its competitors with MarketBeat's FREE daily newsletter.

HCM Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

HCM Stock Analysis - Frequently Asked Questions

HUTCHMED's stock was trading at $14.41 at the beginning of 2025. Since then, HCM shares have decreased by 3.8% and is now trading at $13.8650.
View the best growth stocks for 2025 here
.

HUTCHMED (HCM) raised $100 million in an initial public offering (IPO) on Thursday, March 17th 2016. The company issued 6,100,000 shares at $16.33 per share. BofA Merrill Lynch and Deutsche Bank Securities served as the underwriters for the IPO and Stifel, Canaccord Genuity, Panmure Gordon and CITIC CLSA were co-managers.

HUTCHMED's top institutional investors include Allianz Asset Management GmbH (0.58%), Jane Street Group LLC (0.13%), Amundi (0.09%) and XY Capital Ltd (0.06%).

Shares of HCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HUTCHMED investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Meta Platforms (META), Arista Networks (ANET), GE Aerospace (GE) and ServiceNow (NOW).

Company Calendar

Today
5/29/2025
Next Earnings (Estimated)
6/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HCM
Employees
1,760
Year Founded
2000

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$19.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+43.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$630.20 million
Cash Flow
$0.54 per share
Price / Cash Flow
24.51
Book Value
$4.27 per share
Price / Book
3.10

Miscellaneous

Free Float
168,044,000
Market Cap
$2.31 billion
Optionable
Not Optionable
Beta
0.55

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:HCM) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners